Fringe benefit plans lack many of the restrictions of qualified plans, and, therefore, are relatively inexpensive to implement.
By David B. Mandell, JD, MBA and Carole C. Foos, CPA
By Mark A. Fritz, MD, Bryan J. Kang, MD, Timothy P. Fox, MD, Nicky Bhatia, MD, and Steven M. Mandel, MD
As research continues, new directions in therapy appear to be emerging.
A Q&A with Axel Steiger, Prof. Dr. med.
Researchers investigated the degree to which various common agents, including benzodiazepines and non-benzodiazepine hypnotics, may affect driving ability. Therapy selection and patient counseling are key to safe use.
A Q&A with Amanda Hetland
The Independent Payment Advisory Board was tasked with achieving savings in Medicare but has now been gutted by Congress and may never become operational.
By Zac Haughn, Senior Associate Editor
Movement Disorders Focus
Results of the Phase II SURE-PD study show inosine is safe and tolerable and raises urate levels, which have been inversely related to Parkinson’s progression. Still, patients are cautioned against self-medicating before the next phase of this research effort is completed.